They proposed repeated infusions of MAGT1 mRNA-corrected autologous CD8+ and NK cells as a potential short-term therapy for XMEN patients [16]. The gene discussed is MAGT1; the disease is X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia.